Full Text:   <2814>

CLC number: R363

On-line Access: 

Received: 2005-06-24

Revision Accepted: 2005-11-13

Crosschecked: 0000-00-00

Cited: 3

Clicked: 5849

Citations:  Bibtex RefMan EndNote GB/T7714

-   Go to

Article info.
1. Reference List
Open peer comments

Journal of Zhejiang University SCIENCE B 2006 Vol.7 No.3 P.228-234


Effects of combination of irbesartan and perindopril on calcineurin expression and sarcoplasmic reticulum Ca2+-ATPase activity in rat cardiac pressure-overload hypertrophy

Author(s):  Jiang Qing-Jun, Xu Geng, Mao Fei-Fei, Zhu You-Fa

Affiliation(s):  Department of Cardiology, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310009, China; more

Corresponding email(s):   xugeng@21cn.com

Key Words:  Angiotensin (Ang) II receptor antagonist, Angiotensin-converting enzyme inhibitor, Calcineurin, Sarcoplasmic reticulum Ca2+-ATPase, Pressure overload, Cardiac hypertrophy, Rat

Jiang Qing-Jun, Xu Geng, Mao Fei-Fei, Zhu You-Fa. Effects of combination of irbesartan and perindopril on calcineurin expression and sarcoplasmic reticulum Ca2+-ATPase activity in rat cardiac pressure-overload hypertrophy[J]. Journal of Zhejiang University Science B, 2006, 7(3): 228-234.

@article{title="Effects of combination of irbesartan and perindopril on calcineurin expression and sarcoplasmic reticulum Ca2+-ATPase activity in rat cardiac pressure-overload hypertrophy",
author="Jiang Qing-Jun, Xu Geng, Mao Fei-Fei, Zhu You-Fa",
journal="Journal of Zhejiang University Science B",
publisher="Zhejiang University Press & Springer",

%0 Journal Article
%T Effects of combination of irbesartan and perindopril on calcineurin expression and sarcoplasmic reticulum Ca2+-ATPase activity in rat cardiac pressure-overload hypertrophy
%A Jiang Qing-Jun
%A Xu Geng
%A Mao Fei-Fei
%A Zhu You-Fa
%J Journal of Zhejiang University SCIENCE B
%V 7
%N 3
%P 228-234
%@ 1673-1581
%D 2006
%I Zhejiang University Press & Springer
%DOI 10.1631/jzus.2006.B0228

T1 - Effects of combination of irbesartan and perindopril on calcineurin expression and sarcoplasmic reticulum Ca2+-ATPase activity in rat cardiac pressure-overload hypertrophy
A1 - Jiang Qing-Jun
A1 - Xu Geng
A1 - Mao Fei-Fei
A1 - Zhu You-Fa
J0 - Journal of Zhejiang University Science B
VL - 7
IS - 3
SP - 228
EP - 234
%@ 1673-1581
Y1 - 2006
PB - Zhejiang University Press & Springer
ER -
DOI - 10.1631/jzus.2006.B0228

Aim: To observe effects of angiotensin (Ang) II receptor antagonist (AT1) irbesartan and angiotensin-converting enzyme (ACE) inhibitor perindopril on rat myocardium calcineurin expression and sarcoplasmic reticulum Ca2+-ATPase activity in the model of pressure-overload cardiac hypertrophy. Methods: Forty male adult Sprague Dawley rats were divided into 5 groups. One group was treated by sham operation; four groups were myocardium hypertrophy cases caused by banding aortic above renal artery. Drugs were given one week after operation. Group 1: sham group, rats (n=8) were gavaged with normal saline 2 ml/(kg·d) (ig); Group 2: control group, rats (n=8) were treated with normal saline 2 ml/(kg·d) (ig); Group 3: rats (n=8) were given perindopril 2 mg/(kg·d) (ig); Group 4: rats (n=8) were treated with irbesartan 20 mg/(kg·d) (ig); Group 5: rats (n=8) were given irbesartan 20 mg/(kg·d) plus perindopril 2 mg/(kg·d) (ig). Morphometric determination, calcineurin expression and sarcoplasmic reticulum Ca2+-ATPase activity were done at the end of 6 week of drug intervention. Expression of calcineurin in myocardium was detected by immunohistochemistry. Results: Left ventricular mass index (LVMI), transverse diameter of myocardial cell (TDM), calcineurin activity were remarkably decreased after drug intervention and this decrease was most remarkable in the combination drug therapy group. sarcoplasmic reticulum Ca2+-ATPase activity was increased after drug intervention, especially in the combined drug therapy group. calcineurin expression in myocardium was remarkably decreased after drug intervention. LVMI was positively correlated with TDM and calcineurin, negatively correlated with sarcoplasmic reticulum Ca2+-ATPase. Conclusion: These data suggest that irbesartan and perindopril inhibit cardiac hypertrophy through the increased activity of sarcoplasmic reticulum Ca2+-ATPase and decreased expression of calcineurin. Their combination had better effects on regressing of ventricular hypertrophy.

Darkslateblue:Affiliate; Royal Blue:Author; Turquoise:Article


[1] Barnes, D.M., Dublin, E.A., Fisher, C.J., Levison, D.A., Millis, R.R., 1993. Immunohistochemical detection of p53 protein in mammary carcinoma: an important new independent indicator of prognosis? Hum. Pathol., 24(5):469-476.

[2] Bastie, D., Levitsky, D., Rappaport, L., 1990. Function of the sarcoplasmic reticulum and expression of its Ca2+-ATPase gene in pressure overload-induced cardiac hypertrophy in the rat. Circ. Res., 66(2):554-564.

[3] de Windt, L.J., Lim, H.W., Bueno, O.F., Liang, Q., Delling, U., Braz, J.C., Glascock, B.J., Kimball, T.F., Monte, F.D., Hajjar, R.J., Molkentin, J.D., 2001. Targeted inhibition of calcineurin attenuates cardiac hypertrophy in vivo. Proc. Natl. Acad. Sci. USA, 98:3322-3327.

[4] Devereux, R.B., 1995. Left ventricular geometry, pathophysiology and prognosis. J. Am. Coll. Cardiol., 25(4):885-887.

[5] Doering, C.W., Jalil, J.E., Janicki, J.S., 1988. Collagen network remodelling and diastolic stiffness of the rat left ventricle with pressure overload hypertrophy. Cardiovasc. Res., 22(10):686-695.

[6] Grossman, W., Jones, D., McLaurin, L.P., 1975. Wall stress and patterns of hypertrophy in the human left ventricle. J. Clin. Invest., 55:56-64.

[7] James, P., Inui, M., Tada, M., Chiesi, M., Carafoli, E., 1989. Nature and site of phospholamban regulation of the Ca2+ pump of sarcoplasmic reticulum. Nature, 342(6245):90-92.

[8] Jones, L.R., Besch, H.R., Fleming, J.W., McConnaughey, M.M., Watanabe, A.M., 1979. Separation of vesicles of cardiac sarcolemma from vesicles of cardiac sarcoplasmic reticulum. Comparative biochemical analysis of component activities. J. Biol. Chem., 254(2):530-539.

[9] Kawano, H., Do, Y.S., Kawano, Y., Stames, V., Barr, M., Law, R.E., Hsueh, W.A., 2000. Angiotensin II has multiple profibrotic effects in human cardiac fibroblasts. Circulation, 101(10):1130-1137.

[10] Kimura, Y., Kurzydlowski, K., Tada, M., MacLennan, D.H., 1996. Phospholamban regulates the Ca2+-ATPase through intramembrance interaction. J. Biol. Chem., 271(42):21726-21731.

[11] Levy, D., Garrison, R.J., Savage, D.D., Kannel, W.B., Castelli, W.P., 1990. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham heart study. N. Engl. J. Med., 322:1561-1566.

[12] Lim, H.W., Molkentin, J.D., 1999. Calcineurin and human heart failure [letter] [see comments]. Nat. Med., 5(3):246-247.

[13] Lim, H.W., de Windt, L.J., Steinberg, L., Taigen, T., Witt, S.A., Kimball, T.R., Molkentin, J.D., 2000. Calcineurin expression, activation, and function in cardiac pressure-overload hypertrophy. Circulation, 101:2431-2437.

[14] Molkentin, J.D., Lu, J.R., Antos, C.L., Markham, B., Richardson, J., Robbins, J., Grant, S.R., Olson, E.N., 1998. A calcineurin dependent transcriptional pathway for cardiac hypertrophy. Cell, 93(2):215-228.

[15] Movsesian, M.A., Schwinger, R.H.G., 1998. Calcium sequestration by the sarcoplasmic reticulum in heart failure. Cardiovasc. Res., 37(2):352-359.

[16] Münch, G., Bölck, B., Karczewski, P., Schwinger, R.H.G., 2002. Evidence for calcineurin-mediated regulation of SERCA 2a activity in human myocardium. J. Mol. Cell. Cardiol., 34(3):321-334.

[17] Sadoshima, J., Izumo, S., 1997. The cellular and molecular response of cardiac myocytes to mechanical stress. Ann. Rev. Physiol., 59(1):551-571.

[18] Shen, H., Mirsalimi, S.M., Weiler, J.E., 1991. Effects of mild cardiac hypertrophy, induced by volume overload in turkeys, on myocardial sarcoplasmic reticulum calcium-pump and calcium-channel activities and on the creatine kinase system. Am. J. Vet. Res., 52(9):1527-1530.

[19] Shimoyama, M., Hayashi, D., Takimoto, E., Zou, Y., Oka, T., Uozumi, H., Kudoh, S., Shibasaki, F., Yazaki, Y., Nagai, R., Komuro, I., 1999. Calcineurin plays a critical role in pressure overload-induced cardiac hypertrophy. Circulation, 100(24):2449-2454.

[20] Sussman, M.A., Lim, H.W., Gude, N., Taigen, T., Olson, E.N., Robbins, J., Colbert, M.C., Gualberto, A., Wieczorek, D.F., Molkentin, J.D., 1998. Prevention of cardiac hypertrophy in mice by calcineurin inhibition. Science, 281(5383):1690-1693.

[21] Tada, M., Kirchberger, M.A., Katz, A.M., 1975. Phosphorylation of a 22000-dalton component of the cardiac sarcoplasmic reticulum by adenosine 3′-5′-monophosphate-dependent protein kinase. J. Biol. Chem., 250:2640-2647.

[22] Vikstrom, K.L., Leinwand, L.A., 1996. Contractile protein mutations and heart disease. Curr. Opin. Cell Biol., 8(1):97-105.

[23] Zhang, W., Kowal, R.C., Rusnak, F., 2000. Failure of calcineurin inhibitors to prevent pressure-overload left ventricular hypertrophy in rats. Circ. Res., 84(6):722-728.

Open peer comments: Debate/Discuss/Question/Opinion


Please provide your name, email address and a comment

Journal of Zhejiang University-SCIENCE, 38 Zheda Road, Hangzhou 310027, China
Tel: +86-571-87952783; E-mail: cjzhang@zju.edu.cn
Copyright © 2000 - 2024 Journal of Zhejiang University-SCIENCE